Physiologically based pharmacokinetic modelling to support the development of a sustained-release formulation for the treatment of cryptococcal meningoencephalitis: An MIDD case study

PBPK & PBBM

MIDD

Specific populations

Infectious Diseases

Program strategies and efficiencies

ACoP15 (Nov 2024), Poster: W-029

Eriksson J, Sjögren E, Gillon JY, Goyal V, Satam V, Robinson S, Caplain H, Ribeiro I, Chenel M